HCA Stock Overview
HCA Healthcare, Inc., through its subsidiaries, provides health care services company in the United States.
HCA Healthcare, Inc. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$183.79|
|52 Week High||US$279.02|
|52 Week Low||US$164.47|
|1 Month Change||-8.12%|
|3 Month Change||4.99%|
|1 Year Change||-25.83%|
|3 Year Change||56.26%|
|5 Year Change||139.81%|
|Change since IPO||492.49%|
Recent News & Updates
Does HCA Healthcare (NYSE:HCA) Deserve A Spot On Your Watchlist?
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
HCA Healthcare (NYSE:HCA) Is Reinvesting To Multiply In Value
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Typically...
Bireme Capital - HCA Healthcare: Quite Cheap Despite Many Competitive Advantages
HCA Healthcare, at 10x 2022 earnings at 6/30/22, is quite cheap despite having many competitive advantages. HCA is on track to generate about $60b in revenue for 2022. The stock has appreciated ~230% since our initial purchases, but trades at a lower earnings multiple today due to excellent business results. HCA remains a large position for our firm. The following segment was excerpted from this fund letter. HCA Healthcare (HCA) HCA, at 10x 2022 earnings at 6/30/22, is quite cheap despite having many competitive advantages. HCA is the world’s largest hospital company, with 182 hospitals, 125 ambulatory surgery centers, and thousands of physician clinics. The company was started in 1968 by the Frist family, who to this day hold about $11b worth of shares in the company. HCA sees 2m patients per year and is on track to generate about $60b in revenue for 2022. We have owned the stock for years, first writing about it in 4Q17. Though it has appreciated ~230% since our initial purchases, HCA trades at a lower earnings multiple today due to excellent business results. HCA’s long-term track record is very impressive. They have methodically expanded their healthcare empire over the decades, achieving annual revenue growth of 7% and EBITDA growth of 8% since 2010. This growth has not come with a rise in share count; in fact, shares have declined from 448m in 2013 to 295m today due to repurchases. Instead, the growth has been due to the high returns on capital enjoyed by the firm, with ROIC of more than 20%.HCA’s operating results are also better than most of its peers, many of whom struggle to consistently generate free cash flow and solid returns on capital. Among nonprofits, smaller community hospitals have notoriously weak financials. Health care services businesses consistently over-index in bankruptcy filings. The industry is not for the faint of heart, but HCA has used its scale and financial strength to outperform its peers over a long period of time. And yet, the company continues to trade in line with comps such as Tenet Healthcare (THC). Tenet, which owns 80 hospitals, has closer to 10% returns on capital and 12-15% average EBITDA margins, ratios that are materially lower than HCA’s. HCA has more scale, better margins, less debt, and better occupancy ratios (70% vs 50% last quarter). We fail to see why HCA should trade at 7x EBITDA along with THC. We think it should trade much closer to (if not above) market multiples. But low valuations do have their advantages for cash-flowing companies. HCA has been no exception, with management buying back $8b worth over the past 4 quarters. At current prices, that $8b equates to a roughly 13% buyback yield. HCA remains a large position for our firm.
|HCA||US Healthcare||US Market|
Return vs Industry: HCA underperformed the US Healthcare industry which returned 7.7% over the past year.
Return vs Market: HCA underperformed the US Market which returned -23.2% over the past year.
|HCA Average Weekly Movement||5.6%|
|Healthcare Industry Average Movement||7.9%|
|Market Average Movement||6.8%|
|10% most volatile stocks in US Market||15.5%|
|10% least volatile stocks in US Market||2.8%|
Stable Share Price: HCA is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: HCA's weekly volatility (6%) has been stable over the past year.
About the Company
HCA Healthcare, Inc., through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. It also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities.
HCA Healthcare, Inc. Fundamentals Summary
|HCA fundamental statistics|
Is HCA overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|HCA income statement (TTM)|
|Cost of Revenue||US$37.32b|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
Oct 21, 2022
|Earnings per share (EPS)||22.68|
|Net Profit Margin||10.83%|
How did HCA perform over the long term?See historical performance and comparison